Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo‐controlled, double‐blind, multicenter clinical trial
Background: Pharmacological conversion of paroxysmal atrial fibrillation is frequently necessary. The aim of this study was to compare intravenous propafenone, a class Ic antiar‐rhythmic agent, with placebo in paroxysmal atrial fibrillation (AF) of recent onset (
Gespeichert in:
Veröffentlicht in: | Clinical cardiology (Mahwah, N.J.) N.J.), 1996-05, Vol.19 (5), p.409-412 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Pharmacological conversion of paroxysmal atrial fibrillation is frequently necessary. The aim of this study was to compare intravenous propafenone, a class Ic antiar‐rhythmic agent, with placebo in paroxysmal atrial fibrillation (AF) of recent onset ( |
---|---|
ISSN: | 0160-9289 1932-8737 |
DOI: | 10.1002/clc.4960190515 |